Yolanda Rosi Helfrich, MD
Dermatology
1500 E Medical Center Dr
Ann Arbor, MI 48109
Manage Your Profile
About
Dr. Yolanda Helfrich is Professor of Dermatology, Chief of Medical Dermatology and the Program Director of the Dermatology Residency in the University of Michigan Department of Dermatology. She is a board-certified dermatologist who provides medical dermatology services to patients of all ages within our outpatient clinics.
She has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss). She also has a special interest in rosacea and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board.
Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2005.
Center Memberships
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Research Overview
Throughout her career, Dr. Helfrich has had a strong interest in clinical research. She directed the Program for Clinical Research in Dermatology (PCRiD) in the department from 2008 until 2021, serving as Primary Investigator on numerous departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She also served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit.
Recent Publications
-
Dubocq-Ortiz CN, Cascardo CA, Helfrich YR. JAAD Case Reports, 2026 Jul 27;Journal ArticleSecondary Syphilis Masquerading as Stasis Dermatitis of the Lower Extremities
DOI:10.1016/j.jdcr.2026.06.058 -
Hernandez A, Mulholland K, Rives H, Helfrich Y. Journal of the American Academy of Dermatology, 2026 Jul 7; 95 (1): ab230Proceeding / Abstract / Poster72704 From Teledermatology to In-Person Care: Improving Access to Dermatologic Care in the Uninsured Through a Student Run Free Clinic
DOI:10.1016/j.jaad.2026.04.930 -
Tang M, Herron G, Helfrich Y, Lowe L, Cao S. Journal of the American Academy of Dermatology, 2026 Jul 7; 95 (1): ab109Proceeding / Abstract / Poster76312 Clinical Findings in Cryptococcoid Neutrophilic Dermatosis: A Review of Literature and Single-Center Retrospective Study
DOI:10.1016/j.jaad.2026.04.445 -
Tang M, Herron G, Ning A, Helfrich Y, Lowe L, Cao S. 2026 Mar 27;Proceeding / Abstract / PosterClinical Findings in Cryptococcoid Neutrophilic Dermatosis: A Review of the Literature and Single-Center Retrospective Study (ePoster)
-
Tang M, Herron G, Ning A, Helfrich Y, Lowe L, Cao S. 2025 Oct 23;Proceeding / Abstract / PosterClinical Findings in Cryptococcoid Neutrophilic Dermatosis: A Review of the Literature and Single-Center Retrospective Study
-
Tang M, Ratycz M, Helfrich YR. Jaad Case Reports, 2025 Oct 1; 64: 202 - 204.Journal ArticleDermatoscopy case of the month: Erythromelanosis follicularis faciei et colli
DOI:10.1016/j.jdcr.2024.05.014 -
Ekeh O, Helfrich Y. Journal of the American Academy of Dermatology, 2025 Sep 2; 93 (3): ab280Proceeding / Abstract / Poster61989 Racial Hair Tax: Examining Price Disparities in Hair Care Products Targeting Textured Hair
DOI:10.1016/j.jaad.2025.05.1110 -
Ständer S, Legat FJ, Pink AE, Yosipovitch G, Kwatra SG, Elmariah S, Helfrich Y, Jabbar-Lopez ZK, Noda A, Piketty C. Journal of the American Academy of Dermatology, 2025 Sep 2; 93 (3): ab25Proceeding / Abstract / Poster63358 Characterization of the pruriginous lesion types in individuals with prurigo nodularis and efficacy from the randomized, placebo-controlled, Phase 3 OLYMPIA 1&2 trials
DOI:10.1016/j.jaad.2025.05.106
Featured News & Stories
2024 Resident & Fellow Graduation